Kent and Medway
Joint Medicines Formulary

Hyperkalaemia

NICE Guidance 

TA623: Patiromer for treating hyperkalaemia, February 2020

TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia, September 2019

Refer to local guidance for hyperkalaemia management

Sodium zirconium cyclosilicate (Lokelma) has been approved for long-term use at EKHUFT for hyperkalaemia in adult haemodialysis patients. This should be prescribed by a Renal Specialist only. Refer to EKHUFT Trust Haemodialysis guidelines.

Calcium polystyrene sulfonate (Calcium Resonium)

Go to the EMC website for more information and guidance.

Patiromer calcium

Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.

Sodium zirconium cyclosilicate

Go to NICE for more information and guidance. Go to the EMC website for more information and guidance.
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary